🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study

RecruitingNAAges 18 Years - 65 YearsAllYuzuncu Yil University
NCT07144007 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients scheduled for rhinoplasty * Between 18-65 years * ASA I-II group Exclusion Criteria: * Those who are outside the age range of 18-65 * Those who are ASA III and above * Those with renal,hepatic, cardiac and respiratory diseases * Those with a known allergy to the medication to be used * Those who underwent urinary catheterization
💊

What it tests

  • Dexmedetomidine
  • Propofol
📍

Where

1 site
Van Yüzüncü Yıl University
Van, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy